<?xml version='1.0' encoding='utf-8'?>
<document id="17851564"><sentence text="PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression."><entity charOffset="29-41" id="DDI-PubMed.17851564.s1.e0" text="capecitabine" /></sentence><sentence text="The anticancer agent indisulam was evaluated in a dose-escalation study in combination with capecitabine"><entity charOffset="92-104" id="DDI-PubMed.17851564.s2.e0" text="capecitabine" /></sentence><sentence text=" Severe myelotoxicity was observed after multiple treatment cycles" /><sentence text=" We hypothesized that capecitabine inhibits the synthesis of CYP2C9, which metabolizes indisulam"><entity charOffset="22-34" id="DDI-PubMed.17851564.s4.e0" text="capecitabine" /></sentence><sentence text=" The objectives were to develop a pharmacokinetic/pharmacodynamic (PK/PD) model for the combination treatment and to estimate the impact of a drug-drug interaction on the safety of various dose levels" /><sentence text=" NONMEM was used to develop a PK/PD model, including the impact of capecitabine coadministration on indisulam pharmacokinetics"><entity charOffset="67-79" id="DDI-PubMed.17851564.s6.e0" text="capecitabine" /></sentence><sentence text=" A simulation study was performed to evaluate the risk of dose-limiting neutropenia" /><sentence text=" A time-dependent pharmacokinetic drug-drug interaction resulted in increased exposure to indisulam and in increased myelotoxicity" /><sentence text=" The risk of dose-limiting neutropenia increased with treatment duration and with dose" /><sentence text=" The excessive myelosuppression after multiple cycles may be explained by a pharmacokinetic interaction between indisulam and capecitabine"><entity charOffset="126-138" id="DDI-PubMed.17851564.s10.e0" text="capecitabine" /></sentence><sentence text=" The combination of 550 mg/m(2) indisulam and 1,250 mg/m(2) capecitabine twice daily was considered safe"><entity charOffset="60-72" id="DDI-PubMed.17851564.s11.e0" text="capecitabine" /></sentence><sentence text="" /></document>